1

Inogen

#8637

Rank

$179.61M

Marketcap

US United States

Country

Inogen
Leadership team

Mr. Nabil Shabshab (CEO, Pres & Director)

Ms. Alison Perry Bauerlein (Co-Founder)

Mr. Bart Sanford (Exec. VP of Operations)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Goleta, California, United States
Established
2001
Company Registration
SEC CIK number: 0001294133
Revenue
100M - 500M
Traded as
INGN
Social Media
Overview
Location
Summary
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
History

Inogen’s origins date back to 1998 when founder, President and CEO, Raymond Huggenberger and his team developed Inogen's flagship product, the Inogen One®, for oxygen-dependent individuals.

Mission
Inogen is innovative oxygen. We are committed to increasing the freedom and independence of oxygen therapy patients through innovative products and services. Inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when Mae, a beloved Grandmother, was prescribed oxygen therapy. Learn more about Mae’s Story here: http://www.inogen.com/about-inogen/meet-mae/. Inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. We estimate that more than 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy. Our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. We believe our products allow oxygen therapy patients to reclaim their freedom an
Vision
Inogen's vision is to provide respiratory care with convenience and simplicity for our customers, globally.
Key Team

Ms. Agnes Lee (Sr. VP of Investor Relations & Strategic Planning)

Mr. Jason Somer (Exec. VP, Gen. Counsel & Corp. Sec.)

Dr. Stanislav Glezer M.D., MBA (Exec. VP & CTO)

Ms. Jennifer Yi Boyer (Exec. VP & Chief HR Officer)

Mr. George J. Parr (Exec. VP & Chief Commercial Officer)

Mr. Matthew Pigeon (Investor Relations Officer)

Ms. Kristin A. Caltrider (Exec. VP, CFO & Treasurer)

Recognition and Awards
Inogen has been awarded numerous awards including the Medical Design Excellence Awards and winning Inc.Magazine's Inc.500 Award two consecutive years.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Inogen
Leadership team

Mr. Nabil Shabshab (CEO, Pres & Director)

Ms. Alison Perry Bauerlein (Co-Founder)

Mr. Bart Sanford (Exec. VP of Operations)

Products/ Services
Health Care, Manufacturing, Medical Device
Number of Employees
1,000 - 20,000
Headquarters
Goleta, California, United States
Established
2001
Company Registration
SEC CIK number: 0001294133
Revenue
100M - 500M
Traded as
INGN
Social Media